Transitional Cell Cancer of the Renal Pelvis and Ureter
Showing 1 - 25 of 38
Urothelial Carcinoma of the Renal Pelvis and Ureter, Transitional Cell Cancer of the Renal Pelvis and Ureter Trial (ST-02)
Not yet recruiting
- Urothelial Carcinoma of the Renal Pelvis and Ureter
- Transitional Cell Cancer of the Renal Pelvis and Ureter
- (no location specified)
Nov 7, 2023
Carcinoma, Transitional Cell Carcinoma, Transitional Cell Cancer of the Renal Pelvis and Ureter Trial in Israel, United States
Withdrawn
- Carcinoma
- +2 more
- UGN-101 instillations
-
Los Angeles, California
- +4 more
May 5, 2020
Bladder Cancer, Transitional Cell Cancer of the Renal Pelvis and Ureter, Ureter Cancer Trial in United Kingdom (carboplatin,
Completed
- Bladder Cancer
- +3 more
- carboplatin
- +3 more
-
Glasgow, Scotland, United Kingdom
- +20 more
May 14, 2019
Bladder Cancer, Transitional Cell Cancer of the Renal Pelvis and Ureter, Urethral Cancer Trial in United States (gemcitabine
Completed
- Bladder Cancer
- +2 more
- gemcitabine hydrochloride
- paclitaxel
-
Cedar Rapids, Iowa
- +15 more
Dec 30, 2018
Bladder Cancer, Transitional Cell Cancer of the Renal Pelvis and Ureter, Urethral Cancer Trial in United Kingdom (cisplatin,
Completed
- Bladder Cancer
- +2 more
- cisplatin
- +2 more
-
Bristol, Avon, United Kingdom
- +15 more
Oct 25, 2018
Bladder Cancer, Transitional Cell Cancer of the Renal Pelvis and Ureter Trial in Charlotte, Greensboro, Winston-Salem
Completed
- Bladder Cancer
- Transitional Cell Cancer of the Renal Pelvis and Ureter
- cisplatin
- +3 more
-
Charlotte, North Carolina
- +2 more
Aug 8, 2018
Kidney Cancer or Cancer of Urothelium and in Healthy
Completed
- Bladder Cancer
- +3 more
- immunologic technique
- +2 more
-
Winston-Salem, North CarolinaWake Forest University Comprehensive Cancer Center
Jul 3, 2018
Bladder Cancer, Transitional Cell Cancer of the Renal Pelvis and Ureter, Urethral Cancer Trial in Leeds (cisplatin, gemcitabine
Completed
- Bladder Cancer
- +2 more
- cisplatin
- +3 more
-
Leeds, England, United KingdomLeeds Cancer Centre at St. James's University Hospital
Feb 2, 2018
Bladder Cancer, Transitional Cell Cancer of the Renal Pelvis and Ureter, Urethral Cancer Trial in United States (gemcitabine
Terminated
- Bladder Cancer
- +2 more
- gemcitabine hydrochloride
- paclitaxel
-
Mobile, Alabama
- +91 more
Jul 8, 2016
Bladder Cancer, Transitional Cell Cancer of the Renal Pelvis and Ureter, Urethral Cancer Trial in New York (sunitinib malate)
Completed
- Bladder Cancer
- +2 more
- sunitinib malate
-
New York, New YorkMemorial Sloan-Kettering Cancer Center
Dec 17, 2015
Bladder Cancer, Transitional Cell Cancer of the Renal Pelvis and Ureter Trial in Canada, United States (bortezomib)
Completed
- Bladder Cancer
- Transitional Cell Cancer of the Renal Pelvis and Ureter
-
Chicago, Illinois
- +14 more
Jul 22, 2015
Bladder Cancer, Transitional Cell Cancer of the Renal Pelvis and Ureter Trial in Copenhagen (cisplatin, gemcitabine HCl,
Completed
- Bladder Cancer
- Transitional Cell Cancer of the Renal Pelvis and Ureter
- cisplatin
- +3 more
-
Copenhagen, DenmarkRigshospitalet - Copenhagen University Hospital
Jun 30, 2014
Bladder Cancer, Transitional Cell Cancer of the Renal Pelvis and Ureter, Urethral Cancer Trial in Worldwide (fluorouracil)
Completed
- Bladder Cancer
- +2 more
-
Porto Alegre, Rio Grande do Sul, Brazil
- +61 more
Dec 3, 2013
Bladder Cancer, Transitional Cell Cancer of the Renal Pelvis and Ureter Trial in United States (filgrastim, docetaxel,
Unknown status
- Bladder Cancer
- Transitional Cell Cancer of the Renal Pelvis and Ureter
- filgrastim
- +2 more
-
La Jolla, California
- +11 more
Dec 3, 2013
Bladder Cancer, Transitional Cell Cancer of the Renal Pelvis and Ureter Trial in San Francisco, Tampa (chemo, tipifarnib)
Completed
- Bladder Cancer
- Transitional Cell Cancer of the Renal Pelvis and Ureter
-
San Francisco, California
- +1 more
Dec 3, 2013
Bladder Cancer, Transitional Cell Cancer of the Renal Pelvis and Ureter Trial in Canada, United States (oxaliplatin)
Completed
- Bladder Cancer
- Transitional Cell Cancer of the Renal Pelvis and Ureter
-
Chicago, Illinois
- +13 more
Sep 4, 2013
Genes and Environment in Cancer in East Anglia, Trent, or West
Unknown status
- Bladder Cancer
- +8 more
- DNA analysis
- +3 more
-
Cambridge, England, United KingdomUniversity of Cambridge Cancer Research UK
Aug 23, 2013
Bladder Cancer, Transitional Cell Cancer of the Renal Pelvis and Ureter, Urethral Cancer Trial in Milan (pazopanib HCl,
Completed
- Bladder Cancer
- +2 more
- pazopanib hydrochloride
- fludeoxyglucose F 18
-
Milan, ItalyFondazione Istituto Nazionale dei Tumori
Aug 9, 2013
Bladder Cancer, Transitional Cell Cancer of the Renal Pelvis and Ureter, Urethral Cancer Trial in Barcelona, Madrid (drug,
Unknown status
- Bladder Cancer
- +2 more
- sunitinib malate
- +4 more
-
Barcelona, Spain
- +3 more
Aug 6, 2013
Bladder Cancer, Transitional Cell Cancer of the Renal Pelvis and Ureter Trial in New Orleans (biological, drug, procedure)
Completed
- Bladder Cancer
- Transitional Cell Cancer of the Renal Pelvis and Ureter
- filgrastim
- +5 more
-
New Orleans, LouisianaTulane Cancer Center at Tulane University Hospital and Clinic
Jul 9, 2013
Bladder Cancer, Transitional Cell Cancer of the Renal Pelvis and Ureter Trial in New York (filgrastim, carboplatin, doxorubicin
Completed
- Bladder Cancer
- Transitional Cell Cancer of the Renal Pelvis and Ureter
- filgrastim
- +4 more
-
New York, New York
- +1 more
Jul 2, 2013
Bladder Cancer, Transitional Cell Cancer of the Renal Pelvis and Ureter Trial in New York (filgrastim, cisplatin, doxorubicin
Completed
- Bladder Cancer
- Transitional Cell Cancer of the Renal Pelvis and Ureter
- filgrastim
- +5 more
-
New York, New YorkMemorial Sloan-Kettering Cancer Center
Jul 2, 2013
Bladder Cancer, Transitional Cell Cancer of the Renal Pelvis and Ureter Trial in New York (filgrastim, cisplatin, doxorubicin
Completed
- Bladder Cancer
- Transitional Cell Cancer of the Renal Pelvis and Ureter
- filgrastim
- +4 more
-
New York, New YorkMemorial Sloan-Kettering Cancer Center
Jun 26, 2013